(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AIOPTIMUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AIOPTIMUS

ST13

US500000090483207

Class

42

Filing

90483207

Registration

6742515

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

05/31/2022

Trademark type

Word

Nice classes

42

Filing date

01/22/2021

Registration date

05/31/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/31/2022

Last transaction

05/31/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/20/2021

First use in commerce

01/20/2021

Drawing code

4

Owner type

03

Owner location

Gilbert, AZ, US

Examiner

TENG, SIMON

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AINovo Biotech Inc.

Representatives

Lynn M. Humphreys HOPKINS & CARLEY

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical research and development; Development of computer programs for simulating laboratory experiments; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of online non-downloadable simulation software for modeling biophysical protein simulations for the purposes of developing bioactive molecules in the field of pharmaceuticalsbiotechnologymedicine; Software as a service (SAAS) services featuring software for developing bioactive molecules for therapeutic and diagnostic applications through the use of computational methods informed by reinforcement learningcomputer visiongenerative machine learningsupervised machine learningunsupervised machine learningnatural language processing algorithms for the purposes of optimizing pharmaceuticalbiotechnologicalmedical drugs

Publications

History of USPTO decisions and trademark events.

15 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/31/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/31/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/15/2022

PUBO

PUBLISHED FOR OPPOSITION

03/15/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/23/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/09/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/09/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/09/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/09/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/10/2021

GNRT

NON-FINAL ACTION E-MAILED

08/10/2021

CNRT

NON-FINAL ACTION WRITTEN

08/10/2021

DOCK

ASSIGNED TO EXAMINER

08/03/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/23/2021

NWAP

NEW APPLICATION ENTERED

01/26/2021

Continuous trademark protection

Get notified about every new filing that threatens AIOPTIMUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.